A 60-second COVID-19 breathalyzer test is provisionally approved in Singapore
A new 60-second coronavirus breathalyzer test has been provisionally approved for use alongside antigen rapid tests in Singapore, reported Reuters on Monday.
The test, which was developed by National University of Singapore "spin-off" company Breathonix, can detect COVID-19 infection in under a minute with "more than 90 percent accuracy," a Singapore-based clinical trial found. Users blow into a disposable mouthpiece, where software then "assesses the chemical compounds of the breath" for infection, writes Reuters. Positive tests are later confirmed with a follow-up polymerase chain reaction (PCR) swab test.
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
These 60-second tests could be "key" in re-opening and revitalizing Singapore's travel sector, which has "slowed to a crawl during the pandemic," writes Bloomberg.
More at Reuters.
